Brief: Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics
05/08/2025 14:32
Aug 5 (Reuters) - Y-mAbs Therapeutics Inc YMAB.O: SERB PHARMACEUTICALS AGREES TO ACQUIRE Y-MABS THERAPEUTICS Y-MABS THERAPEUTICS INC: SERB TO COMMENCE ALL-CASH TENDER OFFER TO ACQUIRE ALL OUTSTANDING SHARES OF Y-MABS FOR $8.60 PER SHARE Y-MABS THERAPEUTICS INC - SERB TO BUY Y-MABS IN $412 MILLION DEAL Y-MABS THERAPEUTICS INC - SERB OFFERS $8.60 PER SHARE FOR Y-MABS, 105% PREMIUM Source text: ID:nGNXQ7FMB Further company coverage: YMAB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Y-mAbs Therapeutics
See all newsY-mAbs Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Y-mAbs Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Y-mAbs Therapeutics' Q2 revenue falls 14%
Brief: Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics
Y-mAbs Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary